Valproic Acid

  • TRADE NAMES: Depacon (AbbVie); Depakene (AbbVie); Depakote (AbbVie)
  • INDICATIONS: Seizures, migraine
  • SYNONYM: valproate sodium; divalproex
  • CLASS: Anticonvulsant, Antipsychotic
  • HALF-LIFE: 6–16 hours
LIFE-THREATENING ADVERSE REACTIONS

See full prescribing information for complete boxed warning.

Our database has 153 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 09/07/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top